Medincell SA operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medincell SA with three other pharmaceutical manufacturers in Europe: Oncimmune Holdings PLC of the United Kingdom (2019 sales of £171,000.00 [US$221,215.86 ] of which 100% was Distribution of testing products), Diurnal Group PLC of the United Kingdom (£1.04 million [US$1.35 million] of which 100% was Alkindi), and Oasmia Pharmaceutical AB which is based in Sweden (1.98 million Swedish Kronor [US$207,504.00 ] of which 65% was Sales of goods).

Sales Analysis.